Literature DB >> 26571192

Cyanohydrin as an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease.

Yangyang Zhai1,2, Xiangshuai Zhao1,2, Zhengjie Cui1,2, Man Wang1,2, Yaxin Wang3, Linfeng Li1,2, Qi Sun4, Xi Yang1,2, Debin Zeng1,2, Ying Liu1,2, Yuna Sun5, Zhiyong Lou3, Luqing Shang1,2, Zheng Yin1,2.   

Abstract

Cyanohydrin derivatives as enterovirus 71 (EV71) 3C protease (3C(pro)) inhibitors have been synthesized and assayed for their biochemical and antiviral activities. Compared with the reported inhibitors, cyanohydrins (1S,2S,2'S,5S)-16 and (1R,2S,2'S,5S)-16 exhibited significantly improved activity and attractive selectivity profiles against other proteases, which were a result of the specific interactions between the cyanohydrin moiety and the catalytic site of 3C(pro). Cyanohydrin as an anchoring group with high selectivity and excellent inhibitory activity represents a useful choice for cysteine protease inhibitors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26571192     DOI: 10.1021/acs.jmedchem.5b01013

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  Activity-Based Protein Profiling Identifies ATG4B as a Key Host Factor for Enterovirus 71 Proliferation.

Authors:  Yang Sun; Qizhen Zheng; Yaxin Wang; Zhengyuan Pang; Jingwei Liu; Zheng Yin; Zhiyong Lou
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

2.  Structure of the Enterovirus 71 3C Protease in Complex with NK-1.8k and Indications for the Development of Antienterovirus Protease Inhibitor.

Authors:  Yaxin Wang; Lin Cao; Yangyang Zhai; Zheng Yin; Yuna Sun; Luqing Shang
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

3.  The structure-based design of peptidomimetic inhibitors against SARS-CoV-2 3C like protease as Potent anti-viral drug candidate.

Authors:  Hao Wang; Rongjuan Pei; Xin Li; Weilong Deng; Shuai Xing; Yanan Zhang; Chen Zhang; Shuai He; Hao Sun; Shuqi Xiao; Jin Xiong; Yecheng Zhang; Xinwen Chen; Yaxin Wang; Yu Guo; Bo Zhang; Luqing Shang
Journal:  Eur J Med Chem       Date:  2022-05-13       Impact factor: 7.088

4.  Janus All-Cis 2,3,4,5,6-Pentafluorocyclohexyl Building Blocks Applied to Medicinal Chemistry and Bioactives Discovery Chemistry.

Authors:  Joshua L Clark; Rifahath M Neyyappadath; Cihang Yu; Alexandra M Z Slawin; David B Cordes; David O'Hagan
Journal:  Chemistry       Date:  2021-10-06       Impact factor: 5.020

5.  Enterovirus A71 antivirals: Past, present, and future.

Authors:  Jun Wang; Yanmei Hu; Madeleine Zheng
Journal:  Acta Pharm Sin B       Date:  2021-08-20       Impact factor: 14.903

6.  Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors.

Authors:  Bing Bai; Elena Arutyunova; Muhammad Bashir Khan; Jimmy Lu; Michael A Joyce; Holly A Saffran; Justin A Shields; Appan Srinivas Kandadai; Alexandr Belovodskiy; Mostofa Hena; Wayne Vuong; Tess Lamer; Howard S Young; John C Vederas; D Lorne Tyrrell; M Joanne Lemieux; James A Nieman
Journal:  RSC Med Chem       Date:  2021-08-20

7.  A Conserved Inhibitory Mechanism of a Lycorine Derivative against Enterovirus and Hepatitis C Virus.

Authors:  Yu Guo; Yaxin Wang; Lin Cao; Peng Wang; Jie Qing; Qizhen Zheng; Luqing Shang; Zheng Yin; Yuna Sun
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

8.  Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.

Authors:  Wenhao Dai; Bing Zhang; Xia-Ming Jiang; Haixia Su; Jian Li; Yao Zhao; Xiong Xie; Zhenming Jin; Jingjing Peng; Fengjiang Liu; Chunpu Li; You Li; Fang Bai; Haofeng Wang; Xi Cheng; Xiaobo Cen; Shulei Hu; Xiuna Yang; Jiang Wang; Xiang Liu; Gengfu Xiao; Hualiang Jiang; Zihe Rao; Lei-Ke Zhang; Yechun Xu; Haitao Yang; Hong Liu
Journal:  Science       Date:  2020-04-22       Impact factor: 47.728

Review 9.  Roles of the Picornaviral 3C Proteinase in the Viral Life Cycle and Host Cells.

Authors:  Di Sun; Shun Chen; Anchun Cheng; Mingshu Wang
Journal:  Viruses       Date:  2016-03-17       Impact factor: 5.048

10.  Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.

Authors:  Sho Iketani; Farhad Forouhar; Hengrui Liu; Seo Jung Hong; Fang-Yu Lin; Manoj S Nair; Arie Zask; Yaoxing Huang; Li Xing; Brent R Stockwell; Alejandro Chavez; David D Ho
Journal:  bioRxiv       Date:  2020-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.